Short-Acting Beta Agonists (SABA) clinical trials

Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma

This study is looking into a new medication called Lunsekimig for adults with asthma that is hard to control. It compares Lunsekimig to a dummy treatment (placebo) to see if it helps manage asthma better and if it's safe.